Official UK procurement notice
Chloraprep - Iskus · UK public procurement notice
Authority: Belfast Health & Social Care Trust (NHS & healthcare)
What is being bought
Published requirement descriptionChloraprep - Iskus
CPV: Medical equipments, pharmaceuticals and personal care products
Open work like this
This notice no longer takes bids · live search, filters set
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Iskus Health UK LTDSME | £150,000 † | — | Awarded |
Contracts
Chloraprep - Iskus · Iskus Health UK LTDSME
- Signed
- 3 Feb 2021
- Value
- £150,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 12 Feb 2021, 15:43 GMT
- Last source update
- 12 Feb 2021, 15:43 GMT
- Authority reference
DACPM2021-15- FTS notice number
2021/S 000-002936- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-0292dfFind a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
- Published justification
ChloraPrep is a rapid-acting, persistent, and broad-spectrum antiseptic for a range of major medical procedures. The 2% Chlorhexidine Gluconate/70% Isopropyl Alcohol formulation acts fast on a broad spectrum of bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA The formulation supports Trust infection control guidelines for helping to reduce the incidence of blood stream infections (BSI) and surgical site infections (SSI). This is a branded patent protected medicine
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Iskus HealthAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.